NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have today announced the launch of TrueCourse Biosciences, an integrated CRO that brings together advanced capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex drug discovery programs.
As AI and computational approaches accelerate the drug discovery process, experimental validation remains the deciding factor in determining which candidates to advance. TrueCourse combines expertise across its ecosystem to give customers a clearer picture of how their targets and drug candidates actually behave, turning predictions into confidence before they move forward.
Read more at globenewswire.com.